QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC

Published:2015-07-03 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Yang Yun-Peng,Ma Yu-Xiang,Huang Yan,Zhao Yuan-Yuan,Fang Wen-Feng,Hong Shao-Dong,Tian Ying,Xue Cong,Sheng Jin,Zhang Li

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep11934.pdf

Reference34 articles.

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin. 64, 9–29 (2014).

2. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127, 2893–2917 (2010).

3. Schiller, J. H. et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 346, 92–98 (2002).

4. Ohe, Y. et al. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: four-arm cooperative study in Japan. Ann Oncol. 18, 317–323 (2007).

5. Sato, M., Shames, D. S., Gazdar, A. F. & Minna, J. D. A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol. 2, 327–343 (2007).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical utility of liquid biopsy-based companion diagnostics in the non-small-cell lung cancer treatment;Exploration of Targeted Anti-tumor Therapy;2022-10-31

2. Clinical efficacy and safety of maintenance therapy for advanced non-small cell lung cancer: a retrospective real-world study;World Journal of Surgical Oncology;2021-08-06

3. Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review;Quality of Life Research;2019-11-27

4. Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review;Frontiers in Oncology;2019-08-12

5. Gefitinib for advanced non-small cell lung cancer;Cochrane Database of Systematic Reviews;2018-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3